Posttraumatic stress disorder: An immunological disorder?

Frontiers in Psychiatry

Volumn 8, Issue NOV, 2017, Pages

  Wang, Zhewu ^a,b   Caughron, Blaine ^a   Young, M Rita I ^a,b  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Disorder; Immune; Inflammation; PTSD; Stress

Indexed keywords

ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; CYCLOOXYGENASE 2 INHIBITOR; DRUG METABOLITE; FLUOXETINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IBUPROFEN; IMMUNOPHILIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; SEROTONIN UPTAKE INHIBITOR; STA 21; STAT3 PROTEIN INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; TRYPTOPHAN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VITAMIN D;

ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE DISEASE; CELL FUNCTION; CELL PLASTICITY; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; EXPOSURE; FKBP5 GENE; GENE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PROPHYLAXIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; RESPIRATORY DISTRESS; RHEUMATOID ARTHRITIS; SHORT SURVEY; TH1 CELL; TH17 CELL;

EID: 85033570997     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2017.00222     Document Type: Short Survey

References (86)

1. Dursa EK, Reinhard MJ, Barth SK, Schneiderman AI. Prevalence of a positive screen for PTSD among OEF/OIF and OEF/OIF-era veterans in a large population-based cohort. J Trauma Stress (2014) 27:542-9. doi:10.1002/jts.21956
2. Creamer M, Burgess P, McFarlane AC. Post-traumatic stress disorder: findings from the Australian National Survey of Mental Health and Well-being. Psychol Med (2001) 31:1237-47. doi:10.1017/S0033291701004287
3. Zhou J, Nagarkatti P, Zhong Y, Ginsberg JP, Singh NP, Zhang J, et al. Dysregulation in microRNA expression is associated with alterations in immune functions in combat veterans with post-traumatic stress disorder. PLoS One (2014) 9:e94075. doi:10.1371/journal.pone.0094075
4. Sommershof A, Aichinger H, Engler H, Adenauer H, Catani C, Boneberg EM, et al. Substantial reduction of naive and regulatory T cells following traumatic stress. Brain Behav Immun (2009) 23:1117-24. doi:10.1016/j.bbi.2009.07.003
5. von Kanel R, Hepp U, Kraemer B, Traber R, Keel M, Mica L, et al. Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J Psychiatr Res (2007) 41:744-52. doi:10.1016/j.jpsychires.2006.06.009
6. Wang Z, Mandel H, Levingston CA, Young MRI. An exploratory approach demonstrating immune skewing and a loss of coordination among cytokines in plasma and saliva of veterans with combat-related PTSD. Hum Immunol (2016) 77:652-7. doi:10.1016/j.humimm.2016.05.018
7. Guo M, Liu T, Guo JC, Jiang XL, Chen F, Gao YS. Study on serum cytokine levels in posttraumatic stress disorder patients. Asian Pac J Trop Med (2012) 5:323-5. doi:10.1016/s1995-7645(12)60048-0
8. Cohen M, Meir T, Klein E, Volpin G, Assaf M, Pollack S. Cytokine levels as potential biomarkers for predicting the development of posttraumatic stress symptoms in casualties of accidents. Int J Psychiatry Med (2011) 42:117-31. doi:10.2190/PM.42.2.b
9. Bam M, Yang X, Zhou J, Ginsberg JP, Leyden Q, Nagarkatti PS, et al. Evidence for epigenetic regulation of pro-inflammatory cytokines, interleukin-12 and interferon-γ, in peripheral blood mononuclear cells from PTSD patients. J Neuroimmune Pharmacol (2016) 11:168-81. doi:10.1007/s11481-015-9643-8
10. Voisey J, Young RM, Lawford BR, Morris CP. Progress towards understanding the genetics of posttraumatic stress disorder. J Anxiety Disord (2014) 28:873-83. doi:10.1016/j.janxdis.2014.09.014
11. Romano S, D'Angelillo A, Staibano S, Simeone E, D'Arrigo P, Ascierto PA, et al. Immunomodulatory pathways regulate expression of a spliced FKBP51 isoform in lymphocytes of melanoma patients. Pigment Cell Melanoma Res (2015) 28:442-52. doi:10.1111/pcmr.12378
12. Dunn EC, Solovieff N, Lowe SR, Gallagher PJ, Chaponis J, Rosand J, et al. Interaction between genetic variants and exposure to Hurricane Katrina on post-traumatic stress and post-traumatic growth: a prospective analysis of low income adults. J Affect Disord (2014) 152-154:243-9. doi:10.1016/j.jad.2013.09.018
13. Boscarino JA, Erlich PM, Hoffman SN, Zhang X. Higher FKBP5, COMT, CHRNA5, and CRHR1 allele burdens are associated with PTSD and interact with trauma exposure: implications for neuropsychiatric research and treatment. Neuropsychiatr Dis Treat (2012) 8:131-9. doi:10.2147/ndt.s29508
14. Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB, et al. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA (2008) 299:1291-305. doi:10.1001/jama.299.11.1291
15. Michopoulos V, Rothbaum AO, Jovanovic T, Almli LM, Bradley B, Rothbaum BO, et al. Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma. Am J Psychiatry (2015) 172:353-62. doi:10.1176/appi.ajp.2014.14020263
16. Eraly SA, Nievergelt CM, Maihofer AX, Barkauskas DA, Biswas N, Agorastos A, et al. Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry (2014) 71:423-31. doi:10.1001/jamapsychiatry.2013.4374
17. Breen MS, Maihofer AX, Glatt SJ, Tylee DS, Chandler SD, Tsuang MT, et al. Gene networks specific for innate immunity define post-traumatic stress disorder. Mol Psychiatry (2015) 20:1538-45. doi:10.1038/mp.2015.9
18. Lindqvist D, Dhabhar FS, Mellon SH, Yehuda R, Grenon SM, Flory JD, et al. Increased pro-inflammatory milieu in combat related PTSD-a new cohort replication study. Brain Behav Immun (2017) 59:260-4. doi:10.1016/j.bbi.2016.09.012
19. Bruenig D, Mehta D, Morris CP, Harvey W, Lawford B, Young RM, et al. Genetic and serum biomarker evidence for a relationship between TNFa and PTSD in Vietnam war combat veterans. Compr Psychiatry (2017) 74:125-33. doi:10.1016/j.comppsych.2017.01.015
20. Newton TL, Fernandez-Botran R, Miller JJ, Burns VE. Interleukin-6 and soluble interleukin-6 receptor levels in posttraumatic stress disorder: associations with lifetime diagnostic status and psychological context. Biol Psychol (2014) 99:150-9. doi:10.1016/j.biopsycho.2014.03.009
21. Teche SP, Rovaris DL, Aguiar BW, Hauck S, Vitola ES, Bau CHD, et al. Resilience to traumatic events related to urban violence and increased IL10 serum levels. Psychiatry Res (2017) 250:136-40. doi:10.1016/j.psychres.2017.01.072
22. Gola H, Engler H, Sommershof A, Adenauer H, Kolassa S, Schedlowski M, et al. Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells. BMC Psychiatry (2013) 13:40. doi:10.1186/1471-244x-13-40
23. Morath J, Gola H, Sommershof A, Hamuni G, Kolassa S, Catani C, et al. The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD: evidence from a randomized controlled trial. J Psychiatr Res (2014) 54:1-10. doi:10.1016/j.jpsychires.2014.03.016
24. Jergovic M, Tomicevic M, Vidovic A, Bendelja K, Savic A, Vojvoda V, et al. Telomere shortening and immune activity in war veterans with posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry (2014) 54:275-83. doi:10.1016/j.pnpbp.2014.06.010
25. An K, Salyer J, Kao HF. Psychological strains, salivary biomarkers, and risks for coronary heart disease among hurricane survivors. Biol Res Nurs (2015) 17:311-20. doi:10.1177/1099800414551164
26. Slavish DC, Graham-Engeland JE, Smyth JM, Engeland CG. Salivary markers of inflammation in response to acute stress. Brain Behav Immun (2015) 44:253-69. doi:10.1016/j.bbi.2014.08.008
27. Minetto MA, Gazzoni M, Lanfranco F, Baldi M, Saba L, Pedrola R, et al. Influence of the sample collection method on salivary interleukin-6 levels in resting and post-exercise conditions. Eur J Appl Physiol (2007) 101:249-56. doi:10.1007/s00421-007-0484-x
28. Izawa S, Sugaya N, Kimura K, Ogawa N, Yamada KC, Shirotsuki K, et al. An increase in salivary interleukin-6 level following acute psychosocial stress and its biological correlates in healthy young adults. Biol Psychol (2013) 94:249-54. doi:10.1016/j.biopsycho.2013.06.006
29. Ebersole JL, Nagarajan R, Akers D, Miller CS. Targeted salivary biomarkers for discrimination of periodontal health and disease(s). Front Cell Infect Microbiol (2015) 5:62. doi:10.3389/fcimb.2015.00062
30. Juretic M, Cerovic R, Belusic-Gobic M, Brekalo Prso I, Kqiku L, Spalj S, et al. Salivary levels of TNF-a and IL-6 in patients with oral premalignant and malignant lesions. Folia Biol (2013) 59:99-102
31. van Dooren FE, Schram MT, Schalkwijk CG, Stehouwer CD, Henry RM, Dagnelie PC, et al. Associations of low grade inflammation and endothelial dysfunction with depression-the Maastricht Study. Brain Behav Immun (2016) 56:390-6. doi:10.1016/j.bbi.2016.03.004
32. Lindqvist D, Wolkowitz OM, Mellon S, Yehuda R, Flory JD, Henn-Haase C, et al. Proinflammatory milieu in combat-related PTSD is independent of depression and early life stress. Brain Behav Immun (2014) 42:81-8. doi:10.1016/j.bbi.2014.06.003
33. Gill JM, Saligan L, Lee H, Rotolo S, Szanton S. Women in recovery from PTSD have similar inflammation and quality of life as non-traumatized controls. J Psychosom Res (2013) 74:301-6. doi:10.1016/j.jpsychores.2012.10.013
34. Ghazali NB, Steele M, Koh D, Idris A. The diurnal pattern of salivary IL-1β in healthy young adults. Int J Adolesc Med Health (2017). doi:10.1515/ijamh-2017-0058
35. Nilsonne G, Lekander M, Akerstedt T, Axelsson J, Ingre M. Diurnal variation of circulating interleukin-6 in humans: a meta-analysis. PLoS One (2016) 11:e0165799. doi:10.1371/journal.pone.0165799
36. Breen MS, Tylee DS, Maihofer AX, Neylan TC, Mehta D, Binder E, et al. PTSD blood transcriptome mega-analysis: shared inflammatory pathways across biological sex and modes of trauma. Neuropsychopharmacology (2017). doi:10.1038/npp.2017.220
37. Olff M, van Zuiden M. Neuroendocrine and neuroimmune markers in PTSD: pre-, peri-and post-trauma glucocorticoid and inflammatory dysregulation. Curr Opin Psychol (2017) 14:132-7. doi:10.1016/j.copsyc.2017.01.001
38. Jones ME, Lebonville CL, Barrus D, Lysle DT. The role of brain interleukin-1 in stress-enhanced fear learning. Neuropsychopharmacology (2015) 40:1289-96. doi:10.1038/npp.2014.317
39. Levkovitz Y, Fenchel D, Kaplan Z, Zohar J, Cohen H. Early post-stressor intervention with minocycline, a second-generation tetracycline, attenuates post-traumatic stress response in an animal model of PTSD. Eur Neuropsychopharmacol (2015) 25:124-32. doi:10.1016/j.euroneuro.2014.11.012
40. Wilson CB, McLaughlin LD, Ebenezer PJ, Nair AR, Dange R, Harre JG, et al. Differential effects of sertraline in a predator exposure animal model of post-traumatic stress disorder. Front Behav Neurosci (2014) 8:256. doi:10.3389/fnbeh.2014.00256
41. Gill J, Lee H, Barr T, Baxter T, Heinzelmann M, Rak H, et al. Lower health related quality of life in U.S. Military personnel is associated with service-related disorders and inflammation. Psychiatry Res (2014) 216:116-22. doi:10.1016/j.psychres.2014.01.046
42. O'Donovan A, Cohen BE, Seal KH, Bertenthal D, Margaretten M, Nishimi K, et al. Elevated risk for autoimmune disorders in Iraq and Afghanistan veterans with posttraumatic stress disorder. Biol Psychiatry (2015) 77:365-74. doi:10.1016/j.biopsych.2014.06.015
43. Hobfoll SE, Gerhart JI, Zalta AK, Wells K, Maciejewski J, Fung H. Posttraumatic stress symptoms predict impaired neutrophil recovery in stem cell transplant recipients. Psychooncology (2015) 24:1529-35. doi:10.1002/pon.3761
44. Vaccarino V, Goldberg J, Rooks C, Shah AJ, Veledar E, Faber TL, et al. Post-traumatic stress disorder and incidence of coronary heart disease: a twin study. J Am Coll Cardiol (2013) 62:970-8. doi:10.1016/j.jacc.2013.04.085
45. O'Donovan A, Sun B, Cole S, Rempel H, Lenoci M, Pulliam L, et al. Transcriptional control of monocyte gene expression in post-traumatic stress disorder. Dis Markers (2011) 30:123-32. doi:10.3233/dma-2011-0768
46. Wohleb ES, McKim DB, Shea DT, Powell ND, Tarr AJ, Sheridan JF, et al. Re-establishment of anxiety in stress-sensitized mice is caused by monocyte trafficking from the spleen to the brain. Biol Psychiatry (2014) 75:970-81. doi:10.1016/j.biopsych.2013.11.029
47. Banks WA, Kastin AJ, Broadwell RD. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation (1995) 2:241-8. doi:10.1159/000097202
48. Vargas-Caraveo A, Perez-Ishiwara DG, Martinez-Martinez A. Chronic psychological distress as an inducer of microglial activation and leukocyte recruitment into the area postrema. Neuroimmunomodulation (2015) 22:311-21. doi:10.1159/000369350
49. Ho YH, Lin YT, Wu CW, Chao YM, Chang AY, Chan JY. Peripheral inflammation increases seizure susceptibility via the induction of neuroinflammation and oxidative stress in the hippocampus. J Biomed Sci (2015) 22:46. doi:10.1186/s12929-015-0157-8
50. Cazareth J, Guyon A, Heurteaux C, Chabry J, Petit-Paitel A. Molecular and cellular neuroinflammatory status of mouse brain after systemic lipopolysaccharide challenge: importance of CCR2/CCL2 signaling. J Neuroinflammation (2014) 11:132. doi:10.1186/1742-2094-11-132
51. McKim DB, Patterson JM, Wohleb ES, Jarrett BL, Reader BF, Godbout JP, et al. Sympathetic release of splenic monocytes promotes recurring anxiety following repeated social defeat. Biol Psychiatry (2015) 79:803-13. doi:10.1016/j.biopsych.2015.07.010
52. Cohen H, Ziv Y, Cardon M, Kaplan Z, Matar MA, Gidron Y, et al. Maladaptation to mental stress mitigated by the adaptive immune system via depletion of naturally occurring regulatory CD4+CD25+ cells. J Neurobiol (2006) 66:552-63. doi:10.1002/neu.20249
53. Muhie S, Gautam A, Meyerhoff J, Chakraborty N, Hammamieh R, Jett M. Brain transcriptome profiles in mouse model simulating features of post-traumatic stress disorder. Mol Brain (2015) 8:14. doi:10.1186/s13041-015-0104-3
54. Gautam A, D'Arpa P, Donohue DE, Muhie S, Chakraborty N, Luke BT, et al. Acute and chronic plasma metabolomic and liver transcriptomic stress effects in a mouse model with features of post-traumatic stress disorder. PLoS One (2015) 10:e0117092. doi:10.1371/journal.pone.0117092
55. Liu X, Nemeth DP, Tarr AJ, Belevych N, Syed ZW, Wang Y, et al. Euflammation attenuates peripheral inflammation-induced neuroinflammation and mitigates immune-to-brain signaling. Brain Behav Immun (2016) 54:140-8. doi:10.1016/j.bbi.2016.01.018
56. Devoto C, Arcurio L, Fetta J, Ley M, Rodney T, Kanefsky R, et al. Inflammation relates to chronic behavioral and neurological symptoms in military with traumatic brain injuries. Cell Transplant (2016) 26:1169-77. doi:10.3727/096368916x693455
57. Spencer-Segal JL, Hyzy RC, Iwashyna TJ, Standiford TJ. Psychiatric symptoms in survivors of the acute respiratory distress syndrome: effects of age, sex, and immune modulation. Ann Am Thorac Soc (2017) 14:960-7. doi:10.1513/AnnalsATS.201606-468OC
58. Sandiego CM, Gallezot JD, Pittman B, Nabulsi N, Lim K, Lin SF, et al. Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. Proc Natl Acad Sci U S A (2015) 112:12468-73. doi:10.1073/pnas.1511003112
59. Ye L, Huang Y, Zhao L, Li Y, Sun L, Zhou Y, et al. IL-1β and TNF-α induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase. J Neurochem (2013) 125:897-908. doi:10.1111/jnc.12263
60. Kaur C, Sivakumar V, Zou Z, Ling EA. Microglia-derived proinflammatory cytokines tumor necrosis factor-a and interleukin-1β induce Purkinje neuronal apoptosis via their receptors in hypoxic neonatal rat brain. Brain Struct Funct (2014) 219:151-70. doi:10.1007/s00429-012-0491-5
61. Takeuchi H, Jin S, Wang J, Zhang G, Kawanokuchi J, Kuno R, et al. Tumor necrosis factor-a induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem (2006) 281:21362-8. doi:10.1074/jbc.M600504200
62. Lee YY, Lee EJ, Park JS, Jang SE, Kim DH, Kim HS. Anti-inflammatory and antioxidant mechanism of tangeretin in activated microglia. J Neuroimmune Pharmacol (2016) 11:294-305. doi:10.1007/s11481-016-9657-x
63. Reshef R, Kreisel T, Beroukhim Kay D, Yirmiya R. Microglia and their CX3CR1 signaling are involved in hippocampal-but not olfactory bulb-related memory and neurogenesis. Brain Behav Immun (2014) 41:239-50. doi:10.1016/j.bbi.2014.04.009
64. Qian J, Zhu L, Li Q, Belevych N, Chen Q, Zhao F, et al. Interleukin-1R3 mediates interleukin-1-induced potassium current increase through fast activation of Akt kinase. Proc Natl Acad Sci U S A (2012) 109:12189-94. doi:10.1073/pnas.1205207109
65. Harrison NA, Doeller CF, Voon V, Burgess N, Critchley HD. Peripheral inflammation acutely impairs human spatial memory via actions on medial temporal lobe glucose metabolism. Biol Psychiatry (2014) 76:585-93. doi:10.1016/j.biopsych.2014.01.005
66. Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry (2002) 7:468-73. doi:10.1038/sj.mp.4000995
67. Davis LL, Suris A, Lambert MT, Heimberg C, Petty F. Post-traumatic stress disorder and serotonin: new directions for research and treatment. J Psychiatry Neurosci (1997) 22:318-26
68. Tucker P, Ruwe WD, Masters B, Parker DE, Hossain A, Trautman RP, et al. Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder. Biol Psychiatry (2004) 56:121-8. doi:10.1016/j.biopsych.2004.03.009
69. Kao CY, He Z, Zannas AS, Hahn O, Kuhne C, Reichel JM, et al. Fluoxetine treatment prevents the inflammatory response in a mouse model of posttraumatic stress disorder. J Psychiatr Res (2016) 76:74-83. doi:10.1016/j.jpsychires.2016.02.003
70. Lee B, Sur B, Yeom M, Shim I, Lee H, Hahm DH. Effects of systemic administration of ibuprofen on stress response in a rat model of post-traumatic stress disorder. Korean J Physiol Pharmacol (2016) 20:357-66. doi:10.4196/kjpp.2016.20.4.357
71. Gamble-George JC, Baldi R, Halladay L, Kocharian A, Hartley N, Silva CG, et al. Cyclooxygenase-2 inhibition reduces stress-induced affective pathology. Elife (2016) 5:e14137. doi:10.7554/eLife.14137
72. Kut JL, Young MRI, Crayton JW, Wright MA, Young ME. Regulation of murine T-lymphocyte function by spleen cell-derived and exogenous serotonin. Immunopharmacol Immunotoxicol (1992) 14:783-96. doi:10.3109/08923979209009235
73. Young MR, Kut JL, Coogan MP, Wright MA, Young ME, Matthews J. Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low dose exogenous serotonin. Immunology (1993) 80:395-400
74. Young MRI, Matthews JP. Serotonin regulation of T-cell subpopulations and of macrophage accessory function. Immunology (1995) 84:148-52
75. Rodriguez P, Holowka DW, Marx BP. Assessment of posttraumatic stress disorder-related functional impairment: a review. J Rehabil Res Dev (2012) 49:649-65. doi:10.1682/JRRD.2011.09.0162
76. George S, Motzer RJ, Hammers HJ, Redman BG, Kuzel TM, Tykodi SS, et al. Safety and efficacy of nivolumab in patients with metastatic renal cell carcinoma treated beyond progression: a subgroup analysis of a randomized clinical trial. JAMA Oncol (2016) 2:1179-86. doi:10.1001/jamaoncol.2016.0775
77. Benham H, Nel HJ, Law SC, Mehdi AM, Street S, Ramnoruth N, et al. Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients. Sci Transl Med (2015) 7:290ra87. doi:10.1126/scitranslmed.aaa9301
78. Bluestone JA, Buckner JH, Fitch M, Gitelman SE, Gupta S, Hellerstein MK, et al. Type 1 diabetes immunotherapy using polyclonal regulatory T cells. Sci Transl Med (2015) 7:315ra189. doi:10.1126/scitranslmed.aad4134
79. Rech AJ, Mick R, Martin S, Recio A, Aqui NA, Powell DJ Jr, et al. CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients. Sci Transl Med (2012) 4:134ra62. doi:10.1126/scitranslmed.3003330
80. Park JS, Kwok SK, Lim MA, Kim EK, Ryu JG, Kim SM, et al. STA-21, a promising STAT3 inhibitor that reciprocally regulates Th17 and Treg, inhibits osteoclastogenesis and alleviates autoimmune inflammation. Arthritis Rheum (2014) 66:918-29. doi:10.1002/art.38305
81. Astry B, Venkatesha SH, Moudgil KD. Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis. Cytokine (2015) 74:54-61. doi:10.1016/j.cyto.2014.11.020
82. Valmori D, Raffin C, Raimbaud I, Ayyoub M. Human RORγt+ TH17 cells preferentially differentiate from naive FOXP3+ Treg in the presence of lineage-specific polarizing factors. Proc Natl Acad Sci U S A (2010) 107:19402-7. doi:10.1073/pnas.1008247107
83. Meeker S, Seamons A, Paik J, Treuting PM, Brabb T, Grady WM, et al. Increased dietary vitamin D suppresses MAPK signaling, colitis and colon cancer. Cancer Res (2014) 74:4398-408. doi:10.1158/0008-5472.can-13-2820
84. Joshi S, Pantalena LC, Liu XK, Gaffen SL, Liu H, Rohowsky-Kochan C, et al. 1,25-Dihydroxyvitamin D3 ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol (2011) 31:3653-69. doi:10.1128/MCB.05020-11
85. Dyring-Andersen B, Bonefeld CM, Bzorek M, Lovendorf MB, Lauritsen JP, Skov L, et al. The vitamin D analogue calcipotriol reduces the frequency of CD8+ IL-17+ T cells in psoriasis lesions. Scand J Immunol (2015) 82:84-91. doi:10.1111/sji.12304
86. Walsh JE, Clark AM, Day TA, Gillespie MB, Young MR. Use of 1a,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma. Hum Immunol (2010) 71:659-65. doi:10.1016/j.humimm.2010.04.008